688068:SHA
Beijing Hotgen Biotech Co Ltd
CN¥85.82
arrow_downward
-3.18%(-2.82) 1D
Jun 1, 3:00:03 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 688068...
Open
CN¥90.00
High
CN¥91.99
Low
CN¥85.80
Mkt. cap
8.22B
Avg. vol.
2.35M
Volume
1.85M
52-wk high
CN¥262.22
52-wk low
CN¥74.77
EPS
-CN¥3.08
No. of employees
946
Open
CN¥90.00
High
CN¥91.99
Low
CN¥85.80
Mkt. cap
8.22B
Avg. vol.
2.35M
Volume
1.85M
52-wk high
CN¥262.22
52-wk low
CN¥74.77
EPS
-CN¥3.08
No. of employees
946
News stories
From sources across the web
MarketBeat
·
20 minutes ago
Zoom Communications (NASDAQ:ZM) Stock Price Up 11.2% - Time to Buy?
Brownstone Research
·
49 minutes ago
The NYSE’s Future Buyer
TradingView
·
1 hour ago
BUZZ - S&P 500 sector performance at 12:01 p.m. EDT
Investor's Business Daily
·
5 hours ago
S&P 500: 10 Overvalued Stocks Are Ticking Time Bombs In Your Portfolio
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification.
Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd
AI content may include mistakes. Learn more